Huadong Medicine Chairman Lyu Liang has proposed a mid-2026 dividend plan, suggesting a cash payout of 3.5 yuan per 10 shares, tax included, to all shareholders. The plan does not include bonus shares or conversion of capital reserve into share capital. Based on the company's current total share capital of 1.754 billion shares, the total dividend is estimated at 614 million yuan. In the first quarter of 2026, Huadong Medicine reported revenue of 11.183 billion yuan and net profit attributable to the parent company of 1.002 billion yuan.
Huadong Medicine Co LtdChairman proposes a mid-2026 dividend of 3.5 yuan per 10 shares, signaling shareholder return commitment.